Back to announcement
20260420_MMIX_Laporan Informasi dan Fakta Material_32072156_lamp2.pdf
Other Text extracted MMIXSource file signed link, expires in 15 minutes
Extracted text 3
Page 1
Press Release
MMIX Accelerates in 2026, Focusing on Product Innovation and
Business Expansion
Jakarta, April 2026 – PT Multi Medika Internasional, Tbk. (MMIX) reaffirmed its
commitment to accelerating business growth in 2026 through product innovation,
distribution expansion, and operational efficiency. This was conveyed directly by MMIX
CEO & Founder, Mengky Mangarek, on CNBC Indonesia's Closing Bell - Earnings
Report program.
In the session, Mengky explained that 2025 would be a turning point for the company,
as MMIX successfully turned a loss into a profit. The company recorded a net profit of
IDR 5.2 billion, a 334% year-on-year growth, supported by improved profit quality and
increasingly solid operational efficiency.
In terms of revenue, MMIX recorded growth to IDR 201.5 billion (+5% YoY), with the
largest contribution coming from the baby diaper line, which grew 37.5% YoY and
became the main driver of the company's profitability. This product line demonstrated
stable demand and contributed significantly to the company's profitability. This was
supported by strong volume growth, laying the foundation for sustainable growth.
Furthermore, MMIX also demonstrated significant improvements in business
fundamentals, reflected in Gross Profit Margin (GPM) growth of 8.1% YoY, EBITDA
growth of 33.4% YoY, and improved operating cash flow to Rp46.1 billion. This reflects
the success of the company's strategy to improve efficiency and overall performance.
Page 2
Entering 2026, MMIX is targeting an acceleration phase with more aggressive growth, targeting a revenue increase of up to IDR 382 billion. Key strategies include expanding distribution across modern trade, general trade, and e-commerce channels, as well as diversifying its product portfolio to meet broader consumer needs. In terms of innovation, MMIX continues to introduce new products such as wet tissues and bamboo tissues, as well as products for modern hygiene needs. All of these innovations focus on quality, safety, and convenience for consumers. Bamboo tissue products have even undergone irritation and toxicity tests, further underscoring MMIX's commitment to product quality and safety. To maintain sustainable growth amidst industry dynamics and pressures on consumer purchasing power, MMIX emphasizes operational efficiency. This is achieved through optimizing factory utilization, controlling costs, and diversifying suppliers to maintain stable raw material prices. Furthermore, the company is exploring expansion opportunities through new distribution channels, including collaborations with institutions and communities. These initiatives are expected to broaden market reach and generate additional sales growth without disrupting existing distribution channels. In the long term, MMIX aims to become a major player in the healthcare and consumer goods industry, with a focus on brand strengthening, market expansion, and sustainable growth both domestically and regionally. Through its participation in CNBC Indonesia's Closing Bell program, MMIX not only presented its business performance and strategy but also emphasized the company's direction as an adaptive, innovative company, poised for aggressive growth in 2026.
Page 3
About PT Multi Medika Internasional Tbk: PT Multi Medika Internasional Tbk (MMIX) is a leading Indonesian company operating in the Fast-Moving Consumer Goods (FMCG) sector. Established in 2020, MMIX has been committed to providing high-quality products that meet people's daily needs. With a primary focus on innovation and customer satisfaction, the Company offers a variety of superior products such as bamboo wipes, baby diapers, and high-pH alkaline water. Furthermore, MMIX is actively expanding its distribution network throughout Indonesia through strategic partnerships with leading retailers and distributors. Through these efforts, MMIX continues to strengthen its market position and contribute to improving the quality of life for consumers in various regions. With a vision to become a leader in the FMCG industry, MMIX consistently innovates and adapts to changing market needs, and is committed to providing added value to shareholders and the wider community. For more information, visit our website at www.multimed.co.id For further information: Corporate Secretary PT Multi Medika Internasional Tbk, SOHO CAPITAL, Podomoro City Land 32nd Floor, Suite 3205A Letjen S. Parman St. No. Kav 28, West Jakarta, Indonesia Office: +62815-1919-8888 Email: corpsec@multimed.co.id Website: https://www.multimed.co.id/
Names mentioned 2 people and organisations named in the text · linked when the evidence is strong
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.